Skip to content
10-Q

Quarterly Report

Titan Pharmaceuticals, Inc.

0001829126-25-006318

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 1.33M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.07M sh
Shares Diluted Q2 2025 · Jun 30, 2025 990K sh
Shares Diluted Q2 2025 · Jun 30, 2024 914K sh
Shares Diluted Q2 2025 · Jun 30, 2024 884K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$1.55M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.68M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $2.8M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $2.83M
Stockholders Equity Q2 2025 · Jun 30, 2025 $2.79M
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.88M
Stockholders Equity Q2 2025 · Dec 31, 2024 $2.44M
Stockholders Equity Q2 2025 · Jun 30, 2024 $3.99M
Stockholders Equity Q2 2025 · Mar 31, 2024 $6.09M
Stockholders Equity Q2 2025 · Dec 31, 2023 $6.64M
Current Liabilities Q2 2025 · Jun 30, 2025 $263K
Current Liabilities Q2 2025 · Dec 31, 2024 $483K
Total Liabilities Q2 2025 · Jun 30, 2025 $263K
Total Liabilities Q2 2025 · Dec 31, 2024 $483K
Current Assets Q2 2025 · Jun 30, 2025 $3.05M
Current Assets Q2 2025 · Dec 31, 2024 $2.92M
Total Assets Q2 2025 · Jun 30, 2025 $3.05M
Total Assets Q2 2025 · Dec 31, 2024 $2.92M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.65
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.26
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.29
Eps Diluted Q2 2025 · Jun 30, 2024 −$3.57
Eps Basic Q2 2025 · Jun 30, 2025 −$0.65
Eps Basic Q2 2025 · Jun 30, 2025 −$1.26
Eps Basic Q2 2025 · Jun 30, 2024 −$2.29
Eps Basic Q2 2025 · Jun 30, 2024 −$3.57
Net Income Q2 2025 · Jun 30, 2025 −$689K
Net Income Q2 2025 · Jun 30, 2025 −$1.25M
Net Income Q2 2025 · Jun 30, 2024 −$2.09M
Net Income Q2 2025 · Jun 30, 2024 −$3.15M
Operating Income Q2 2025 · Jun 30, 2025 −$657K
Operating Income Q2 2025 · Jun 30, 2025 −$1.19M
Operating Income Q2 2025 · Jun 30, 2024 −$2.07M
Operating Income Q2 2025 · Jun 30, 2024 −$3.14M